ELANElanco Animal Health

Median target
$30
calls from the last 12 months
Implied return
+31.9%
median target vs. price
Coverage
15 analysts · 17 calls
updated in the last 12 months
Consensus
14/1/0+14 net
Buy / Hold / Sell

Which analysts are behind ELAN's consensus?

See every current rating, price target and the analysts' track records for Elanco Animal Health — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 15 analysts with calls on ELAN updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ELAN elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-20InsidersKurzius Lawrence ErikDirectorInsider purchase40.0K sh @ $23.40$936K
2026-08-18InsidersO'Neill ShivGC AND CORP SECInsider purchase4.0K sh @ $23.58$94K
2026-08-12InsidersHarrington Michael JDirectorInsider purchase5.0K sh @ $21.82$109K
2026-08-07InsidersHerendeen PaulDirectorInsider purchase10.0K sh @ $23.68$237K
2026-08-07InsidersVanhimbergen Robert MEVP and CFOInsider purchase4.2K sh @ $23.08$97K
2025-04-11ExecutiveTrump, Donald JPresidentPurchaseELANCO ANIMAL HEALTH INC$1,001 - $150,004
2023-03-06CongressDaniel GoldmanNY-NY10Salesince trade +106.8%, vs market -10.4%$1K–$15K
2020-11-05CongressKatherine M. ClarkMA-MA05Salesince trade -31.2%, vs market +165.8%$1K–$15K
2020-10-22CongressKatherine M. ClarkMA-MA05Purchasesince trade -28.1%, vs market -166.5%$1K–$15K
2020-10-22CongressKatherine M. ClarkMA-MA05Purchasesince trade -28.1%, vs market -166.5%$1K–$15K

More: congressional trades on ELAN · insider activity · executive branch · trending